Streptozocine Keocyt

Streptozocine Keocyt is an intravenous chemotherapy medication used primarily for pancreatic cancer treatment. This alkylating agent works by slowing or stopping cancer cell growth. Always consult a healthcare provider for personalized guidance.

Streptozocine Keocyt is primarily used to treat pancreatic cancer, a type of cancer that starts in the pancreas. It may also be used in certain cases of malignant carcinoid tumors. This medication works by interfering with the growth of cancer cells, helping to control or reduce tumor size. It is typically administered under medical supervision.

Streptozocine Keocyt may cause side effects such as nausea, vomiting, or fatigue during treatment. Some patients report changes in kidney function or blood cell counts. These effects vary by individual and are monitored closely by healthcare providers. Hydration and rest are often recommended during therapy.

Streptozocine Keocyt should be handled with care, as it may cause harm if it comes into contact with skin or eyes. Patients should report any signs of infection, unusual bleeding, or severe side effects to their doctor immediately. Regular blood tests are typically required to monitor organ function during treatment.

Streptozocine Keocyt may interact with other medications, including certain chemotherapy drugs or medications that affect kidney function. Alcohol and other substances that stress the liver or kidneys should be avoided unless approved by a healthcare provider. Always inform your doctor about all medications and supplements you are taking.